- Home
- MOBX vs ANL Comparison
MOBX vs ANL Comparison
Compare MOBX & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOBX
- ANL
- Stock Information
- Founded
- MOBX 2020
- ANL 2004
- Country
- MOBX United States
- ANL Cayman Islands
- Employees
- MOBX N/A
- ANL N/A
- Industry
- MOBX
- ANL
- Sector
- MOBX
- ANL
- Exchange
- MOBX Nasdaq
- ANL Nasdaq
- Market Cap
- MOBX 57.1M
- ANL 61.8M
- IPO Year
- MOBX N/A
- ANL 2023
- Fundamental
- Price
- MOBX $0.93
- ANL $1.79
- Analyst Decision
- MOBX
- ANL Hold
- Analyst Count
- MOBX 0
- ANL 1
- Target Price
- MOBX N/A
- ANL N/A
- AVG Volume (30 Days)
- MOBX 1.7M
- ANL 11.6K
- Earning Date
- MOBX 08-13-2025
- ANL 09-26-2025
- Dividend Yield
- MOBX N/A
- ANL N/A
- EPS Growth
- MOBX N/A
- ANL N/A
- EPS
- MOBX N/A
- ANL N/A
- Revenue
- MOBX $10,984,000.00
- ANL N/A
- Revenue This Year
- MOBX N/A
- ANL N/A
- Revenue Next Year
- MOBX N/A
- ANL N/A
- P/E Ratio
- MOBX N/A
- ANL N/A
- Revenue Growth
- MOBX 180.13
- ANL N/A
- 52 Week Low
- MOBX $0.55
- ANL $1.10
- 52 Week High
- MOBX $2.47
- ANL $3.89
- Technical
- Relative Strength Index (RSI)
- MOBX 45.49
- ANL 60.76
- Support Level
- MOBX $1.00
- ANL $1.65
- Resistance Level
- MOBX $1.19
- ANL $1.91
- Average True Range (ATR)
- MOBX 0.16
- ANL 0.10
- MACD
- MOBX -0.01
- ANL 0.00
- Stochastic Oscillator
- MOBX 14.17
- ANL 58.02
About MOBX Mobix Labs Inc.
Mobix Labs Inc. specializes in designing, developing, and selling components and systems for wireless and wired connectivity, radio frequency (RF) technologies, switching, and electromagnetic interference (EMI) filtering solutions. The company serves markets, including commercial, industrial, automotive, medical, aerospace, defense, and others.
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.